DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pseudotyping
Pseudotyping
Neutralizing Antibody Against SARS-Cov-2 Spike in COVID-19 Patients, Health Care Workers, and Convalescent Plasma Donors
SARS-Cov-2 RBD Antibodies That Maximize Breadth and Resistance to Escape W 1,15 2,15 3,15 4 Tyler N
Spread of a SARS-Cov-2 Variant Through Europe in the Summer of 2020
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-Cov-2 Spike Protein for Neutralization Assays
Enhanced Pseudotyping Efficiency of HIV-1 Lentiviral Vectors by A
Biosafety Manual
Lentiviral Vectors Pseudotyped with Baculovirus Gp64 Efficiently
Broad Sarbecovirus Neutralization by a Human Monoclonal Antibody
Viral Vectors 101 a Desktop Resource
Pseudotyping of VSV with Ebola Virus Glycoprotein Is Superior to HIV-1 For
Vesiculovirus G Protein-Based Stable Cell Lines for Continuous Lentiviral Vector Production
Endoplasmic Reticulum Chaperone Gp96 Is Essential for Infection with Vesicular Stomatitis Virus
Lentiviral Vectors Pseudotyped with Glycoproteins from Ross River and Vesicular Stomatitis Viruses: Variable Transduction Related to Cell Type and Culture Conditions
Rapid Assessment of SARS-Cov-2 Evolved Variants Using Virus-Like
A Simplified SARS-Cov-2 Pseudovirus Neutralization Assay
Efficient Pseudotyping of Different Retroviral Vectors Using a Novel
Rabies Glycoprotein-Mediated Uptake Into Epithelial Cells and Compartmentalized Primary Neuronal Culture
More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation
Top View
Factors Affecting Transduction Efficiency of Pseudotyped Viral Vectors Incorporating Alphaviral Glycoproteins Aditi Kesari Purdue University
Introduction to Viral Vector Safety Amanda Haley, Ph.D., RBP, MRSB
Dissertation Pseudotyping of Lentiviral Vector With
Pseudotyping of Moloney Leukemia Virus-Based Retroviral Vectors with Simian Immunodeficiency Virus Envelope Leads to Targeted Infection of Human CD4+ Lymphoid Cells
PDF Version of Viral Vector Requirements
Biological Safety Guide
Characteristics of Antibody Interactions and Immunogenicity
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV
Effects of Spike Mutations in SARS-Cov-2 Variants of Concern on Human Or Animal ACE2-Mediated Virus Entry and Neutralization
No False Start for Novel Pseudotyped Vectors David Avram Sanders
Neutralizing Antibody Against SARS-Cov-2 Spike in COVID-19 Patients, Health Care Workers, and Convalescent Plasma Donors
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Lentiviral Vector Bioprocessing
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies
Viral Vectors in Neurobiology: Therapeutic and Research Applications
Complete Mapping of Mutations to the SARS-Cov-2 Spike Receptor-Binding Domain That Escape Antibody Recognition
The Lentiviral Vector Pseudotyped by Modified Rabies Glycoprotein Does Not Cause Reactive Gliosis and Neurodegeneration in Rat Hippocampus
VSV-G Pseudotyping Rescues HIV-1 CA Mutations That Impair Core
Rapid Quantification of SARS-Cov-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System Dimple Khetawat, Christopher C Broder*
Pseudotyped Lentiviral Vectors: One Vector, Many Guises
Pseudotyping of Murine Leukemia Virus with the Envelope
Influence of Different Glycoproteins and of the Virion Core on SERINC5
Principles of Molecular Virology
Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
Dartmouth College Institutional Biosafety Committee Viral Vector
A Simplified SARS-Cov-2 Pseudovirus Neutralization Assay
Characterisation of Antibody Interactions with the G Protein of Vesicular Stomatitis 2 Virus Indiana Strain and Other Vesiculovirus G Proteins
Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges
Effective Screening of SARS-Cov-2 Neutralizing Antibodies in Patient Serum Using Lentivirus Particles Pseudotyped with SARS-Cov